| Trial ID: | L2216 |
| Source ID: | NCT02457130
|
| Associated Drug: |
Ticagrelor
|
| Title: |
Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)
|
| Acronym: |
TICS-DM
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Coronary Artery Disease|Diabetes Mellitus. Type 2
|
| Interventions: |
DRUG: Ticagrelor|DRUG: Clopidogrel
|
| Outcome Measures: |
Primary: Platelet reactivity, maximal platelet aggregation, measured with light transmittance aggregometry (using 20 μM ADP as agonist), achieved after 1 week of treatment with ticagrelor or clopidogrel, 7 days |
|
| Sponsor/Collaborators: |
Sponsor: Spanish Society of Cardiology | Collaborators: AstraZeneca
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-04
|
| Completion Date: |
2017-02
|
| Results First Posted: |
|
| Last Update Posted: |
2016-04-14
|
| Locations: |
Hospital Universitari de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, 30120, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT02457130
|
